drugset
drugset / Trial / NCT03542006

Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy

NCT03542006 ↗

Phase 2 Unknown 35 enrolled Tel-Aviv Sourasky Medical Center
NaSingle-groupOpen-labelTreatment

Summary

Examine the efficacy of brinzolamide for the treatment of central serous chorioretinopathy

Timeline

Start
2018-06-01
Primary completion
2019-01-01
Completion
2019-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Brinzolamide Small molecule — Topical

Indications

central serous chorioretinopathy